Disclosures for "The Phase 3 RESILIENT Study: Taldefgrobep Alfa in Spinal Muscular Atrophy"
-
Dr. Lair has received personal compensation for serving as an employee of Biohaven. An immediate family member of Dr. Lair has received personal compensation for serving as an employee of CVS Health. An immediate family member of Dr. Lair has received personal compensation for serving as an employee of PPD/Thermo Fisher Scientific. Dr. Lair has stock in Biohaven. An immediate family member of Dr. Lair has stock in Aetna/CVS. An immediate family member of Dr. Lair has stock in PPD/Thermo Fisher Scientific. Dr. Lair has a non-compensated relationship as a Board Member with NY State Neurological Society that is relevant to AAN interests or activities.
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.
-
-
Susan Durham has received personal compensation for serving as an employee of Biohaven. Susan Durham has stock in Biohaven.
-
Dr. Campbell has received personal compensation for serving as an employee of Biohaven. Dr. Campbell has stock in Biohaven.
-
Mrs. Marin has nothing to disclose.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.